Volume 42; Issue 4

European Respiratory Journal

Volume 42; Issue 4
4

Sildenafil: a definitive NO in COPD

Year:
2013
Language:
english
File:
PDF, 290 KB
english, 2013
10

From pollen count to pollen potency: the molecular era of aerobiology

Year:
2013
Language:
english
File:
PDF, 312 KB
english, 2013
11

No TWEAK for COPD

Year:
2013
Language:
english
File:
PDF, 195 KB
english, 2013
14

Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?

Year:
2013
Language:
english
File:
PDF, 298 KB
english, 2013
15

Adopting universal lung function reference equations

Year:
2013
Language:
english
File:
PDF, 271 KB
english, 2013
18

Future directions for the ERS: Presidential plans

Year:
2013
Language:
english
File:
PDF, 440 KB
english, 2013
26

Allergic burden and the risk of venous thromboembolism

Year:
2013
Language:
english
File:
PDF, 228 KB
english, 2013
30

Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes

Year:
2013
Language:
english
File:
PDF, 155 KB
english, 2013
31

Allergic burden and the risk of venous thromboembolism

Year:
2013
Language:
english
File:
PDF, 164 KB
english, 2013
32

Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD

Year:
2013
Language:
english
File:
PDF, 282 KB
english, 2013
33

Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes

Year:
2013
Language:
english
File:
PDF, 218 KB
english, 2013
35

"Lung function, race and ethnicity: a conundrum." Philip H. Quanjer. Eur Respir J 2013; 41: 1249-1251.

Year:
2013
Language:
english
File:
PDF, 138 KB
english, 2013
37

Prof. Isabelle Tillie-Leblond

Year:
2013
Language:
english
File:
PDF, 205 KB
english, 2013
45

Biomarker-guided clinical decisions: for patients, health economists or neither?

Year:
2013
Language:
english
File:
PDF, 278 KB
english, 2013
47

Early patterns of wheezing in asthmatic and nonasthmatic children

Year:
2013
Language:
english
File:
PDF, 402 KB
english, 2013